Predicting neoadjuvant chemotherapy benefit using deep learning from stromal histology in breast cancer
F. Li, Y. Yang, Y. Wei, Y. Zhao, J. Fu, X. Xiao, Z. Zheng, H. Bu
This study uses deep learning to predict neoadjuvant chemotherapy benefit in breast cancer using stromal histology, introducing the TS-score which outperforms existing predictors.
bioRxiv · Jun 19, 2022Pathology